Normal view MARC view ISBD view

Ophthalmic drug delivery systems / edited by Ashim K. Mitra.

Contributor(s): Mitra, Ashim K, 1954-.
Material type: TextTextSeries: Drugs and the pharmaceutical sciences: Publisher: New York : Marcel Dekker, c2003Edition: 2nd ed. Rev. and expanded.Description: xiv, 727 p. : ill. ; 24 cm.ISBN: 0824741242; 9780824741242.Subject(s): Ophthalmic drugs | Drug delivery systems | Eye diseases -- drug therapy | Ophthalmic Solutions -- administration & dosageDDC classification: 617.7061 Online resources: Publisher description | WorldCat details | E-book Fulltext
Contents:
Table of contents Fundamental considerations: overview of ocular drug delivery, Sreeraj Macha, Patrick M. Hughes, and Ashim K. Mitra; membrane transport processes in the eye, Gangadhar Sunkara and Uday Kompella; general considerations in ocular drug disposition, JamesE. Chastain. Transport models in ocular drug delivery: ocular drug transfer following systemic drug administration, Nelson L. Jumbe and Michael Miller; ocular pharmacokinetics and pharmacodynamics, Ronald Schoenwald; mathematical modelling of drugdistribution in the vitreous humour, Stuart Friederich, Bradley Saville, and Yu-Ling Cheng; anterior segment microdialysis, Kay Rittenhouse; posterior segment microdialysis, Sreeraj Macha and Ashim K. Mitra. Drug delivery systems: conventional systems;ocular penetration enhancers, Thomas Wai-Yip Lee and Joseph Robinson; corneal collagen shields for ocular delivery, Shiro Higaki, Marvin E. Myles, Jeanette M. Loutsch, and James M. Hill; the non-corneal route in ocular drug delivery, Imran Ahmed; oculariontophoresis, Marvin E. Myles, Jeanete M. Loutsch, Shiro Higaki, and James M. Hill; mucoadhesive polymers in ophthalmic drug delivery, Thomas Johnston, Clapton Dias, Hemant Alur and Ashim K. Mitra; microparticulates and nanoparticles in ocular drugdelivery, Murali K. Kothuri, Swathi Pinnamaneni, Nandita G. Das, and Sudip K. Das; dendrimers - an innovative and enhanced ocular drug delivery system, jeanette M. Loutsch, Desiree Ong, and James M. Hill; delivery of macromolecular therapeutic agents;ocular delivery and therapeutics of peptides and proteins, Surajit Dey, Ramesh Krishnamurthy, and Ashim K. Mitra; retinal disease models for development of drug and gene therapies, Leena Pitkanen, Lotta Salminen, and Arto Urtti; new experimentaltherapeutic approaches for degenerative diseases of the retina, Joyce Tombran-Tink; gene, oligonucleotide and ribozyme therapy in the eye, Sudip K. Das and Keith J. Miller. Regulatory aspects: regulatory considerations, Robert E. Roehrs and Scott D.Krueger; patent considerations, Robert E. Roehrs.
Summary: The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Collection Call number Status Date due Barcode Item holds
E-Book E-Book EWU Library
E-book
Non-fiction 617.7061 OPH 2003 (Browse shelf) Not for loan
Total holds: 0

Includes bibliographical references and index.

Table of contents Fundamental considerations: overview of ocular drug delivery, Sreeraj Macha, Patrick M. Hughes, and Ashim K. Mitra; membrane transport processes in the eye, Gangadhar Sunkara and Uday Kompella; general considerations in ocular drug disposition, JamesE. Chastain. Transport models in ocular drug delivery: ocular drug transfer following systemic drug administration, Nelson L. Jumbe and Michael Miller; ocular pharmacokinetics and pharmacodynamics, Ronald Schoenwald; mathematical modelling of drugdistribution in the vitreous humour, Stuart Friederich, Bradley Saville, and Yu-Ling Cheng; anterior segment microdialysis, Kay Rittenhouse; posterior segment microdialysis, Sreeraj Macha and Ashim K. Mitra. Drug delivery systems: conventional systems;ocular penetration enhancers, Thomas Wai-Yip Lee and Joseph Robinson; corneal collagen shields for ocular delivery, Shiro Higaki, Marvin E. Myles, Jeanette M. Loutsch, and James M. Hill; the non-corneal route in ocular drug delivery, Imran Ahmed; oculariontophoresis, Marvin E. Myles, Jeanete M. Loutsch, Shiro Higaki, and James M. Hill; mucoadhesive polymers in ophthalmic drug delivery, Thomas Johnston, Clapton Dias, Hemant Alur and Ashim K. Mitra; microparticulates and nanoparticles in ocular drugdelivery, Murali K. Kothuri, Swathi Pinnamaneni, Nandita G. Das, and Sudip K. Das; dendrimers - an innovative and enhanced ocular drug delivery system, jeanette M. Loutsch, Desiree Ong, and James M. Hill; delivery of macromolecular therapeutic agents;ocular delivery and therapeutics of peptides and proteins, Surajit Dey, Ramesh Krishnamurthy, and Ashim K. Mitra; retinal disease models for development of drug and gene therapies, Leena Pitkanen, Lotta Salminen, and Arto Urtti; new experimentaltherapeutic approaches for degenerative diseases of the retina, Joyce Tombran-Tink; gene, oligonucleotide and ribozyme therapy in the eye, Sudip K. Das and Keith J. Miller. Regulatory aspects: regulatory considerations, Robert E. Roehrs and Scott D.Krueger; patent considerations, Robert E. Roehrs.

The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery.

Pharmacy

There are no comments for this item.

Log in to your account to post a comment.

Library Home | Contacts | E-journals
Copyright @ 2011-2019 EWU Library
East West University